Flower to Beverages: Cannabis Retail's Next Category Shift
Photo by Leonid Altman via Pexels.
Walk into almost any dispensary in the country right now and the shelf space tells you what the register already knows: flower still wins. For the 12 months ending September 2026, flower pulled in $9.6 billion, or 39.1% of all tracked US cannabis sales, according to Headset's point-of-sale data. No other format comes close. But that number is doing something quietly important in the background -- it dropped 0.7 percentage points over the same stretch, even as the dollar figure stayed dominant. That's not a category in freefall. It's a mature category losing altitude a little at a time, the way market leaders usually do before something else starts eating their lunch.
Meanwhile, beverages are still a rounding error in the national picture -- $299 million, just 1.2% of tracked sales. But they grew 9.3% year-over-year, and in California, the single most mature legal cannabis market in the country, beverages were the fastest-growing category of anything on the shelf at 17.2%. That gap between the national share and the mature-market growth rate is the whole story of this piece.
This isn't a trend piece built on vibes or a single press release. It's sitting inside real POS data through September 2026, and it collides with a regulatory deadline -- December 11, 2026 -- that's about to hit the parallel hemp-derived beverage market just as this publishes. So the question worth actually answering, not just gesturing at, is whether beverages are repeating the pre-roll playbook of the last several years, a genuine format rotation that reshapes category share for good, or whether they're a smaller niche that a federal THC milligram cap boxes in before it ever gets the chance to scale.
What the Headset Numbers Actually Say
In the 12 months ending September 2026, Beverages (+9.3%) and Pre-Rolls (+10.7%) posted solid year-over-year sales growth, while Flower sales declined slightly (-0.7%), signaling a shift in consumer preference away from traditional flower products.
Start with the plain arithmetic, because it's easy to let a growth-rate headline obscure it: flower is still the largest category in US cannabis retail by a wide margin, at $9.6 billion and 39.1% of tracked sales for the 12 months ending September 2026. Nothing else is within striking distance of that number in absolute dollars. If you only looked at total revenue, you'd conclude flower's dominance is basically unchanged.
But share is a different measure than revenue, and share is where the erosion shows up. Flower's 39.1% reflects a 0.7 percentage point decline over the trailing year. That's not a collapse -- it's the kind of slow bleed you'd expect from a mature, saturated category where most of the growth has already happened and newer formats are picking off the margin. A 0.7-point move in a single year, compounded over three or four years, is the difference between a category that quietly stays dominant and one that gets meaningfully smaller as a share of the pie.
The categories picking up that margin are telling. Pre-rolls grew 10.7% year-over-year and beverages grew 9.3% -- the two fastest-growing formats nationally, and neither of them is about chasing higher potency. Pre-rolls succeeded by removing a manual step (grinding and rolling), and beverages are built around a fixed, often low dose per serving. Both formats compete on convenience and portion control rather than on THC percentage, which is itself a signal about where consumer preference is drifting, even while high-potency flower and concentrates still have a loyal base.
It's worth stating plainly, though, so the growth-rate headline doesn't get overread: beverages are still small. $299 million and 1.2% of tracked sales is a niche category today, full stop. The more striking number for understanding where this is heading isn't the national share -- it's what's happened in markets that have had the most time to mature. In California, extract-based 2.0 formats -- vapes, edibles, and beverages combined -- have reportedly reached roughly 51.7% combined share, meaning flower is already a minority of spend in the oldest legal market in the country. That's the leading indicator worth watching more closely than the national blended number.
California and New York as Early Indicators
If national data tells you a trend might be starting, mature-market data tells you what it looks like once it's had room to run. California and New York are useful here precisely because they're not newer, thinner markets still figuring out distribution -- they're dense, high-population markets with established dispensary networks and, increasingly, the cold-chain delivery infrastructure that refrigerated beverages actually require.
California beverages posted 17.2% year-over-year sales growth and 17.8% unit growth in September 2026 -- the fastest of any category in the state that month, beating pre-rolls, vapes, and everything else on the shelf. At the same time, flower sales in California fell 2.3% over the same period, a sharper decline than the national flower trend of -0.7 points in share. If California is a preview of where other mature markets are headed, that preview includes an actual dollar contraction in flower, not just slower relative growth.
New York adds a second data point that's smaller in absolute terms but arguably more interesting in its internal mechanics. New York beverages hit $2.5 million in September 2026 sales, up 16.1% year-over-year -- solid, roughly in line with California's trajectory. But unit sales surged 32.6%, nearly double the dollar growth rate. That gap between unit growth and revenue growth suggests either price compression (beverages getting cheaper per unit as competition increases) or a proliferation of smaller-format products -- more cans, lower price points, more frequent purchase occasions rather than fewer, pricier ones. Either reading points toward beverages normalizing into a routine purchase rather than a novelty one.
One brand detail worth flagging: Ayrloom led New York's beverage growth specifically. In flower, strain names and THC percentages still do a lot of the purchasing work -- consumers shop by cultivar more than by cultivator. A branded product leading growth in beverages is an early signal that this format may behave more like a packaged-goods category, where consistency and brand trust matter more than any single batch's terpene profile.
The honest caveat: California and New York aren't representative of the whole country. Both have dense dispensary networks, established delivery logistics, and enough population density to support cold-chain beverage distribution economically. A rural or newly legal market without that infrastructure may not replicate this pattern on the same timeline, if at all -- so treat these two states as early indicators, not a guaranteed national forecast.
Why Beverages Specifically -- The Consumption Logic
Photo by Sophie Nouveau via Pexels.
The appeal of a cannabis beverage isn't really about the cannabis -- it's about what it removes. Edibles have existed in legal markets for well over a decade, and one of their persistent limitations has been dosing anxiety: a gummy's onset can take 45 minutes to two hours, which leads some consumers to take a second dose before the first has kicked in, and that unpredictability has kept a lot of canna-curious and older consumers at arm's length. Beverages don't fully solve onset time -- they're still an edible route of administration -- but many are formulated for faster onset than solid edibles, and the serving itself is visually and socially familiar in a way a gummy package isn't.
That familiarity does real work. A seltzer at a barbecue or a drink after work fits into existing social rituals that smoking and vaping simply don't for a large swath of adults, including plenty who drink alcohol but have never owned a grinder or a vape pen. This is close to the same logic that helped pre-rolls succeed: pre-rolls stripped away the equipment and skill barrier of rolling your own joint, and went from a minor afterthought in dispensary sales to a double-digit-growth category over several years specifically by removing friction, not by offering something flower couldn't already do. Beverages are following a similar pattern, just removing a different kind of friction -- the apparatus and ritual of consumption rather than the preparation step.
But the pre-roll comparison only goes so far, and the more sobering precedent is edibles themselves. Gummies and chocolates have been widely available in legal markets for more than ten years, consumer awareness is high, and they still haven't displaced flower as the dominant category anywhere. That's real evidence that convenience alone doesn't guarantee category dominance -- there's apparently a ceiling even for formats that solve genuine pain points, and beverages could plateau well below flower's share rather than overtake it, following the edibles pattern rather than the pre-roll one.
There's also a purely operational constraint that pre-rolls and edibles don't face to the same degree: cold-chain logistics. Many cannabis beverages require refrigeration, which means dispensary coolers, temperature-controlled trucks, and shorter shelf life than a shrink-wrapped pre-roll or a shelf-stable gummy. Those are real costs that could cap how fast beverage distribution scales even in markets where demand is clearly there -- infrastructure, not consumer interest, may end up being the binding constraint.
The Hemp-Beverage Wildcard Outside Dispensaries
Photo by Stephen Kong via Unsplash.
Here's where the story splits into two parallel markets that look similar from a distance but aren't the same thing at all. Everything described so far -- the Headset numbers, the California and New York data -- comes from licensed dispensaries operating under state cannabis programs. But there's a second, faster-scaling beverage channel that doesn't touch a dispensary at all: hemp-derived THC drinks sold in ordinary grocery and convenience retail, legal under the 2018 Farm Bill's definition of hemp as cannabis with no more than 0.3% delta-9 THC by dry weight.
That channel is moving at a different speed and through different doors. Sprouts is launching an eight-brand hemp beverage lineup -- including Cann, Nowadays, Wynk, and Magic Cactus -- statewide in two markets. Target is piloting hemp THC drinks in 10 Twin Cities stores. Circle K has announced plans to sell THC drinks in up to 3,000 locations. None of these retailers hold a cannabis dispensary license; they're selling under the hemp carve-out, in stores most Americans already walk into every week.
The growth numbers reflect that reach. NielsenIQ reportedly measured $239 million in THC beverage sales over its latest 52-week period, up 135% year-over-year -- a growth rate that dwarfs the 9.3% national and 17.2% California figures from the licensed dispensary channel. That's not because hemp beverages are inherently more appealing; it's largely a function of distribution. There are roughly 13,000 licensed dispensaries in the US. Grocery, convenience, and big-box retail footprints are an order of magnitude larger, and a product sitting in a Circle K cooler reaches a completely different, much larger pool of casual and first-time buyers than one sitting behind a dispensary counter.
The critical thing to hold onto is that these two channels are legally distinct and regulated under entirely different frameworks -- state cannabis licensing on one side, the federal hemp definition on the other. That distinction isn't a technicality. It's the reason one of these markets is about to hit a wall that the other one won't.
The December 11 Deadline and What It Breaks
Photo by RDNE Stock project via Pexels.
That wall has a date on it: December 11, 2026. P.L. 119-37, also known as H.R. 5371, was signed into law November 12, 2025, and it redefines hemp at the federal level with a cap of 0.4 milligrams of total THC per container in finished hemp products. To put that in context, that threshold sits far below what current hemp THC beverages typically contain -- most of the products now on Sprouts, Target, and Circle K shelves were formulated for a market without that ceiling.
The original enforcement date was November 12, 2026, one year after signing. H.R. 6500, signed September 2, 2026, pushed that enforcement date to December 11, 2026 for most hemp cannabinoids -- but notably not for synthetic cannabinoids that can't be naturally produced by Cannabis sativa L., like Delta-8 and HHC, which stay on the original November 2026 timeline. That's a split deadline that treats product chemistry differently depending on whether the cannabinoid occurs naturally in the plant or is synthesized, and it means the compliance calendar isn't one date, it's two.
Practically, that means the Sprouts, Target, and Circle K rollouts described above are racing a compliance cliff measured in weeks from this article's publication, not years. A retailer that just launched an eight-brand hemp beverage program statewide has a matter of weeks to either reformulate to 0.4 mg per container, pull the products, or find some other path to compliance.
Reasoning from precedent here is more useful than guessing at outcomes. The 2026 Farm Bill passed the House 224-200 on April 30 and left the THC cap intact, and the White House has signaled no further extensions. Past hemp-regulation deadlines -- going back to state-level crackdowns on Delta-8 and other hemp-derived cannabinoids over the past several years -- have typically played out as some mix of enforcement delays, product reformulation toward compliant dosing, and a persistent gray market that keeps selling non-compliant product regardless of the rule. There's no strong historical case for assuming either flawless enforcement or another clean postponement; the realistic expectation, based on how these things have gone before, is a messy middle: some brands reformulate and survive, some retailers quietly stop carrying the category, and some non-compliant product keeps circulating anyway.
What doesn't change regardless of how that plays out: licensed dispensary beverages, the Headset/California/New York numbers discussed earlier, are regulated under state cannabis programs, not the federal hemp definition. They are not subject to this deadline. The rotation happening inside licensed dispensaries and the hemp-retail boom happening in grocery aisles are running on different regulatory clocks, even though from a distance -- can of cannabis-infused seltzer, either way -- they look like the same trend.
What a Real Rotation Would Require to Stick
Photo by goldmanandyoung via Pixabay.
For beverages to actually dent flower's 39.1% share in a lasting way, rather than just being the fastest-growing slice of a category that's still small, the current growth rates would need to compound for several more years without hitting a demand ceiling. Growth near 9% nationally or 17% in a mature market like California looks impressive in a single year; sustained at that pace for three or four years running, it starts to meaningfully reshape the category mix. The question is whether that pace holds as the base gets bigger, since growth rates almost mechanically decelerate as a category matures -- which is exactly what flower itself demonstrates right now.
The conservative case leans on the edibles precedent discussed earlier: a genuinely convenient, decade-plus-old format that never displaced flower and instead settled into a durable but secondary share. If beverages follow that arc, a plausible outcome is a mid-single-digit national share within a few years -- a real category, a real business, but not a flower replacement.
The bull case leans on a different analogy: hard seltzer's normalization of flavored alcohol in grocery aisles over the past decade, which pulled in a wave of occasional and lighter drinkers who weren't big beer or liquor consumers before. If the hemp-channel distribution survives the December 11 deadline in reformulated, lower-dose form -- genuinely compliant at 0.4 mg per container rather than just rebranded -- the combined licensed-plus-hemp beverage market could do something similar for cannabis: normalize a low-dose drink as a mainstream grocery-aisle product that brings in consumers who'd never buy flower or a vape pen in the first place.
Over the next 12 to 18 months, a few concrete indicators will tell you which case is winning. Watch whether California's 17% beverage growth holds or decelerates as the category's base expands -- deceleration would support the edibles-ceiling case. Watch whether other mature markets like Colorado and Michigan start showing the same flower-to-beverage share shift California is showing, which would suggest this is a structural pattern rather than a California-specific quirk. And watch how many national retailers keep a hemp THC drink program on shelves twelve months after the December deadline forces reformulation -- that number will tell you whether the grocery-aisle channel survives as a scaled business or shrinks back to a handful of committed brands.
There's a business opportunity angle worth naming plainly: the scarce input in this rotation isn't likely to be brand marketing, it's going to be beverage manufacturing capacity, cold-chain distribution, and low-dose formulation expertise capable of hitting a 0.4 mg compliance target without the drink tasting like an afterthought. That's a close parallel to how pre-roll automation equipment became a quiet, profitable niche in the supply chain during that category's rise -- the winners weren't necessarily the flashiest brands, they were the companies solving the unglamorous production problem everyone else needed solved.
The data does support a real, measurable rotation. Pre-rolls and beverages are growing faster than flower by a wide margin, flower's share is declining in both the national numbers and more sharply in mature markets like California, and extract-based formats have already become the majority of spend where the market has had the longest time to settle. That's not speculation -- it's what the POS data for the 12 months ending September 2026 actually shows.
But calling a 1.2%-share, $299 million category a flower replacement overstates what the numbers have proven so far. Beverages are the fastest-growing format in several markets, not the largest, and the one format with over a decade of track record in solving a similar convenience problem -- edibles -- never got past being a secondary category. The honest read is that beverages have earned their growth rate, not yet their ceiling.
The more consequential near-term event isn't actually a demand shift at all. It's December 11, 2026, and whether the grocery and convenience retail channel -- the part of this story growing at 135% a year, an order of magnitude faster than anything inside a licensed dispensary -- survives in anything like its current form once the 0.4 mg cap takes effect. That deadline will do more to shape where cannabis beverages stand a year from now than any single quarter of dispensary sales data.
Anyone sizing up this rotation as a business opportunity should watch Sprouts, Target, and Circle K specifically over the coming months, not as retail trivia but as the real test case. Reformulated, genuinely compliant low-dose products that stay on those shelves past the deadline will say far more about whether beverages have staying power than this quarter's 17% growth number does. A category that survives a regulatory cap intact tells you something about durable demand. A category that evaporates the moment the dose drops tells you the growth was mostly about potency and novelty all along -- and that's a very different bet to be making right now.
